Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature

Herz. 2010 Jan;35(1):43-9. doi: 10.1007/s00059-010-3262-1. Epub 2010 Feb 9.

Abstract

Background and purpose: The occurrence of acute myocardial infarction (AMI) in patients with idiopathic thrombocytopenic purpura (ITP) is rare, especially when the platelet count is low. Since only few case reports have been published, there are no recommendations for the management of thrombocytopenic patients with AMI. The aim of the present study is to discuss different aspects of this challenging issue and to review limited data available in the literature.

Case study: An 80-year-old patient with ITP (platelet count 5 . 10(9)/l) is presented who developed an AMI (ST segment elevation myocardial infarction) and was successfully treated by primary percutaneous coronary intervention (PCI).

Conclusion: Considering the high bleeding risk in patients with ITP and AMI, careful balance between usual anticoagulation and antiplatelet therapy on the one hand, and efforts to raise platelet count on the other hand are needed.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary*
  • Comorbidity
  • Coronary Angiography
  • Danazol / administration & dosage
  • Drug Therapy, Combination
  • Echocardiography
  • Electrocardiography
  • Estrogen Antagonists / administration & dosage
  • Humans
  • Male
  • Myocardial Infarction / blood
  • Myocardial Infarction / complications*
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / blood
  • Purpura, Thrombocytopenic, Idiopathic / complications*

Substances

  • Adrenal Cortex Hormones
  • Estrogen Antagonists
  • Platelet Aggregation Inhibitors
  • Danazol